Tasfigo tablets 35mg, manufactured by Eisai, contain Tazemetostat hydrobromide. This medication is used to treat certain sarcomas and follicular lymphomas, is standardized as 35mg per tablet, and has a YJ code of 4291087F1020.
Tasfigo tablets 35mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
